Edwards Lifesciences Corporation Income (Loss) from Continuing Operations, Per Diluted Share
Edwards Lifesciences Corporation (EW) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.42 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-04
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was $0.42, a 26.32% decline year-over-year.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was $0.66, a 6.45% increase year-over-year.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was $0.50, a 18.03% decline year-over-year.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was $0.57, a 6.56% decline year-over-year.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for fiscal 2025 was $1.81, a 22.65% decline from fiscal 2024.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for fiscal 2024 was $2.34, a 16.42% increase from fiscal 2023.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for fiscal 2023 was $2.01, a 5.19% decline from fiscal 2022.
- Edwards Lifesciences Corporation income (loss) from continuing operations, per diluted share for fiscal 2022 was $2.12.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.42 10-Q · filed 2026-08-04 | $1.07 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | $0.66 10-Q · filed 2026-05-06 | ||||
| 2025-12-31 | $1.81 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $0.50 10-Q · filed 2025-11-05 | $1.70 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | $0.57 10-Q · filed 2026-08-04 | $1.20 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | $0.62 10-Q · filed 2026-05-06 | ||||
| 2024-12-31 | $0.58 10-K · filed 2025-02-28 | $2.34 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $0.61 10-Q · filed 2025-11-05 | $1.75 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | $0.61 10-Q · filed 2025-08-06 | $1.15 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $0.54 10-Q · filed 2025-05-06 | ||||
| 2023-12-31 | $0.55 10-K · filed 2025-02-28 | $2.01 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $0.55 10-K · filed 2025-02-28 | $1.46 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $0.41 10-K · filed 2025-02-28 | $0.42 10-Q · filed 2024-07-31 | $0.91 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | $0.49 10-K · filed 2025-02-28 | ||||
| 2022-12-31 | $2.12 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |